Potaba

— THERAPEUTIC CATEGORIES —

Miscellaneous urogenital disorders

PAGE CONTENTS

Jump to Section

Generic Name & Formulations

Indications

Dosage and Administration

Contraindications

Boxed Warnings

Warnings/Precautions

Pharmacokinetics

Interactions

Adverse Reactions

Clinical Trials

Note

Patient Counseling

Potaba Generic Name & Formulations

Legal Class

General Description

Aminobenzoate potassium 500mg; caps.

Pharmacological Class

Antifibrotic.

How Supplied

Caps—250, 1000

Manufacturer

Glenwood, LLC

Potaba Indications

Indications

Peyronie's disease (possibly effective).

Potaba Dosage and Administration

Adult

12g daily in 4–6 divided doses.

Children

1g daily in divided doses for each 10lbs of body weight.

Potaba Contraindications

Contraindications

Concomitant sulfonamides.

Potaba Boxed Warnings

Not Applicable

Potaba Warnings/Precautions

Warnings/Precautions

Interrupt therapy if anorexia or nausea occur. Renal disease. Pregnancy. Nursing mothers.

Potaba Pharmacokinetics

See Literature

Potaba Interactions

Interactions

See Contraindications.

Potaba Adverse Reactions

Adverse Reactions

Anorexia, nausea, fever, rash.

Potaba Clinical Trials

See Literature

Potaba Note

Not Applicable

Potaba Patient Counseling

See Literature